TheraRadar
Landscape Cardiovascular

Myocardial Infarction Clinical Trial Landscape

Data updated: May 20, 2026

484 clinical trials tracked since 2008

Myocardial Infarction is being studied across 484 clinical trials registered since 2008, with 99 programs currently active. The competitive pipeline includes 27 active Phase 3 trials, 23 active Phase 2 trials, and 4 active Phase 1 trials. Top industry sponsors include Novo Nordisk, Beijing Sungen Biomedical Technology Co., Ltd, Beijing Northland Biotech. Co., Ltd..

99 active
/
484 total (since 2008)
4
Phase 1 Active
45 total
23
Phase 2 Active
153 total
27
Phase 3 Active
138 total
48
Phase 4 Active
195 total

Top Industry Sponsors

Sorted by active Active Done Failed
Novo Nordisk 2 0 0
Beijing Sungen Biomedical Technology Co., Ltd 1 2 0
Beijing Northland Biotech. Co., Ltd. 1 2 0
Viatris Innovation GmbH 1 1 0
CeleCor Therapeutics 1 1 0

+ 10 more sponsors — see full table below

Featured Phase 3 Trials

NCT07478003 RECRUITING
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
Thomas Engstrom n=5,204
NCT06118281 RECRUITING
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Novo Nordisk A/S n=10,000
NCT07276282 RECRUITING
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
ECRI bv n=332
NCT07052799 RECRUITING
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Chinese University of Hong Kong n=2,514
NCT07380919 RECRUITING
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
Federico II University n=100

+ 133 more Phase 3 trials — see full database below

Myocardial Infarction — Trials Started by Year (last 10 years)

2016
26
2017
26
2018
26
2019
15
2020
17
2021
31
2022
25
2023
15
2024
19
2025
27
2026
20

TheraRadar.com

Full Trial Database

Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.

Top Sponsors (all-time)

Novo Nordisk
2
Beijing Sungen Biomedical Technology Co., Ltd
3
Beijing Northland Biotech. Co., Ltd.
3
Viatris Innovation GmbH
2
CeleCor Therapeutics
2
CorFlow Therapeutics AG
2
Ever Supreme Bio Technology Co., Ltd.
2
Nyrada Pty Ltd
1
Implicit Bioscience
1
ECRI bv
1

Active Trials by Phase

Phase 1
4
Phase 2
23
Phase 3
27
Phase 4
48

Enrollment Size Distribution

1-50
110
51-200
167
201-500
67
501-1k
29
1k+
85

All Industry Sponsors

Sorted by active Active Done Failed
Novo Nordisk 2 0 0
Beijing Sungen Biomedical Technology Co., Ltd 1 2 0
Beijing Northland Biotech. Co., Ltd. 1 2 0
Viatris Innovation GmbH 1 1 0
CeleCor Therapeutics 1 1 0
CorFlow Therapeutics AG 1 1 0
Ever Supreme Bio Technology Co., Ltd. 1 1 0
Nyrada Pty Ltd 1 0 0
Implicit Bioscience 1 0 0
ECRI bv 1 0 0
HONYA Medical Co Ltd 1 0 0
Amgen 1 0 0
ResoTher Pharma 1 0 0
Shanghai Hutchison Pharmaceuticals Limited 1 0 0
Viscofan 1 0 0
NCT04957719 ENROLLING BY INVITATION
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Viatris Innovation GmbH n=25,000
NCT07478003 RECRUITING
Prehospital Pulse-dose Glucocorticoid in Patients With ST-segment Elevation Myocardial Infarction 2 - The PULSE-MI 2 Trial
Thomas Engstrom n=5,204
NCT06118281 RECRUITING
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Novo Nordisk A/S n=10,000
NCT07276282 RECRUITING
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
ECRI bv n=332
NCT07052799 RECRUITING
Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/or Polypectomy
Chinese University of Hong Kong n=2,514
NCT07380919 RECRUITING
Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study
Federico II University n=100
NCT07301034 RECRUITING
A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack
Novo Nordisk A/S n=332
NCT07257198 RECRUITING
Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone
Montreal Heart Institute n=2,570
NCT07445737 NOT YET RECRUITING
Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
Assistance Publique - Hôpitaux de Paris n=700
NCT06174753 RECRUITING
Dapagliflozin in STEMI
Ottawa Heart Institute Research Corporation n=256
NCT05577988 RECRUITING
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome
Assistance Publique - Hôpitaux de Paris n=2,468
NCT07320625 RECRUITING
Efficacy of Montelukast on STEMl Patients
Shanghai Zhongshan Hospital n=512
NCT07295223 RECRUITING
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Instituto Mexicano del Seguro Social n=44
NCT07297589 RECRUITING
Epicardial Cardiac Fat-CT (EPIC-CT)
Instituto Mexicano del Seguro Social n=136
NCT07229248 RECRUITING
DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial
National Institute of Cardiovascular Diseases, Pakistan n=496
NCT04825743 ACTIVE NOT RECRUITING
A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI
CeleCor Therapeutics n=2,463
NCT07174414 NOT YET RECRUITING
Cilostazol for Prevention of Recurrent Stroke Trial
Stanford University n=2,000
NCT05476991 RECRUITING
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
Assistance Publique - Hôpitaux de Paris n=2,800
NCT06081803 ACTIVE NOT RECRUITING
Evolocumab in STEMI
Sejong General Hospital n=166
NCT01878344 ACTIVE NOT RECRUITING
Effects of N-acetyl Cysteine During Primary Percutaneous Coronary Intervention
Suleyman Demirel University n=100
NCT06286878 RECRUITING
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
University of Sao Paulo n=80
NCT06847568 RECRUITING
The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
Ain Shams University n=1,000
NCT06619600 ACTIVE NOT RECRUITING
Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction
Hospital Clinic of Barcelona n=54
NCT06742567 RECRUITING
Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
National Institute of Cardiovascular Diseases, Pakistan n=472
NCT06364150 RECRUITING
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Seoul National Hospital n=30
NCT06704685 NOT YET RECRUITING
A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI
Xiangya Hospital of Central South University n=40
NCT05182970 RECRUITING
Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
Karolinska Institutet n=5,160
NCT03335839 COMPLETED
Adjunctive, Low-dose tPA in Primary PCI for STEMI
Population Health Research Institute n=210
NCT01652209 COMPLETED
To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction.
Pharmicell Co., Ltd. n=90
NCT04420624 TERMINATED
COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction
University Hospital, Montpellier n=54
NCT04837001 COMPLETED
Evaluation in STEMI Patients Using FDY-5301
Faraday Pharmaceuticals, Inc. n=2,351
NCT01502774 COMPLETED
Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
Hospices Civils de Lyon n=970
NCT07146360 COMPLETED
Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction
AO GENERIUM n=180
NCT06318481 COMPLETED
TADCLOT- a Double Blind Randomized Controlled Trial
National Institute of Cardiovascular Diseases, Pakistan n=2,200
NCT00673842 COMPLETED
Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
University of Calgary n=700
NCT02596126 COMPLETED
Secondary Prevention of Cardiovascular Disease in the Elderly Trial
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III n=2,499
NCT02733185 COMPLETED
Trial to Assess Chelation Therapy 2
Mt. Sinai Medical Center, Miami n=1,000
NCT02301910 COMPLETED
Single Bolus Recombinant Nonimmunogenic Staphylokinase Versus Single Bolus Tenecteplase (Metalyse) in STEMI
Supergene, LLC n=382
NCT04564742 COMPLETED
Dapagliflozin Effects on Cardiometabolic Outcomes in Patients With an Acute Heart Attack.
AstraZeneca n=4,017
NCT04509674 COMPLETED
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
Boehringer Ingelheim n=6,522
NCT05424315 COMPLETED
Impact of DApagliflozin on Cardiac Function Following Anterior Myocardial Infarction in Non-Diabetic Patients
Omar Younis n=100
NCT05043610 COMPLETED
MSCs for Prevention of MI-induced HF
Shiraz University of Medical Sciences n=420
NCT03048825 COMPLETED
Colchicine and Spironolactone in Patients with MI / SYNERGY Stent Registry
Population Health Research Institute n=7,264
NCT03087773 COMPLETED
Impact of EMpagliflozin on Cardiac Function and Biomarkers of Heart Failure in Patients With Acute MYocardial Infarction
Medical University of Graz n=476
NCT05077683 COMPLETED
Direct Oral Anticoagulants for Prevention of lEft ventRIcular Thrombus After Anterior Acute Myocardial InFarction - APERITIF
Assistance Publique - Hôpitaux de Paris n=560
NCT02981407 COMPLETED
Myocardial Ischemia and Transfusion
Rutgers, The State University of New Jersey n=3,506
NCT03991000 TERMINATED
Iron in Patients With Cardiovascular Disease
Dr. med. Mahir Karakas n=8
NCT02548364 COMPLETED
Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz n=109
NCT04571580 TERMINATED
Effect of Low-dose Intracoronary Reteplase on Myocardial Infarct Size During Primary Percutaneous Coronary Intervention
Ge Junbo n=36
NCT02976701 TERMINATED
Effect of DLBS1033 After Primary PCI in Patients With STE-ACS
Dexa Medica Group n=23
NCT05998525 COMPLETED
Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography
Hilda Elizabeth Macías Cervantes n=54
NCT02924727 COMPLETED
Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
Novartis Pharmaceuticals n=5,669
NCT03251859 COMPLETED
Effectiveness of Lower Maintenance Dose of Ticagrelor Early After Myocardial Infarction (ELECTRA) Pilot Study
Collegium Medicum w Bydgoszczy n=52
NCT05705089 COMPLETED
Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI
Rajaie Cardiovascular Medical and Research Center n=50
NCT04838808 COMPLETED
Rivaroxaban in Type 2 Myocardial Infarctions
University of Alberta n=8
NCT03649711 COMPLETED
Chronic Kidney Disease (CKD) Platelet Study
University of Arkansas n=76
NCT00650143 COMPLETED
Sitagliptin Plus Granulocyte-colony Stimulating Factor in Acute Myocardial Infarction
Ludwig-Maximilians - University of Munich n=174
NCT04739384 COMPLETED
Platelet Inhibition With Ticagrelor 60 mg Versus Ticagrelor 90 mg in Elderly Patients With ACS
Federico II University n=50
NCT04637555 WITHDRAWN
Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)
Novartis Pharmaceuticals
NCT03822377 COMPLETED
Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
Azienda Ospedaliero Universitaria di Sassari n=130
NCT03232398 COMPLETED
Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
Hadassah Medical Organization n=40
NCT01569178 COMPLETED
BAMI. The Effect of Intracoronary Reinfusion of Bone Marrow-derived Mononuclear Cells(BM-MNC) on All Cause Mortality in Acute Myocardial Infarction
Queen Mary University of London n=375
NCT03404063 COMPLETED
Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI)
John Paul II Hospital, Krakow n=105
NCT01305226 COMPLETED
A Trial Using Double-Bolus THR-100 Versus Streptokinase
Bharat Biotech International Limited n=120
NCT01969890 TERMINATED
STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial
Heart Care Foundation n=532
NCT03516903 TERMINATED
Effect of Methotrexate Carried by a Lipid Nanoemulsion on Left Ventricular Remodeling After STEMI
University of Sao Paulo n=35
NCT02404376 COMPLETED
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Hospital Universitari Vall d'Hebron Research Institute n=378
NCT02551094 COMPLETED
Colchicine Cardiovascular Outcomes Trial (COLCOT)
Montreal Heart Institute n=4,745
NCT02617290 COMPLETED
Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
Assistance Publique - Hôpitaux de Paris n=1,900
NCT02377388 COMPLETED
DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function
University of Sao Paulo General Hospital n=74
NCT04421274 COMPLETED
Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction
Affiliated Hospital of North Sichuan Medical College n=43
NCT03234348 COMPLETED
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
Hospital Clinic of Barcelona n=151
NCT01950299 COMPLETED
Interleukin-1 (IL-1) Blockade in Acute Myocardial Infarction (VCU-ART3)
Virginia Commonwealth University n=99
NCT02429271 COMPLETED
A Multicenter Trial to Assess the MIcrovascular Integrity and Left Ventricular Function Recovery After Clopidogrel or TicagrelOr Administration, in Patients With STEMI Treated With Thrombolysis - The 'MIRTOS' Study
Hellenic Cardiovascular Research Society n=336
NCT02803073 WITHDRAWN
Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial Infarction
Texas Tech University Health Sciences Center
NCT00623623 COMPLETED
STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction
Boehringer Ingelheim n=1,899
NCT01167582 COMPLETED
Myocardial Ischemia and Transfusion Pilot
Rutgers, The State University of New Jersey n=110
NCT02298088 COMPLETED
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
Hospital do Coracao n=3,799
NCT02565147 TERMINATED
Bivalirudin Infusion for Ventricular Infarction Limitation
The Medicines Company n=78
NCT00617123 COMPLETED
Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
Merck Sharp & Dohme LLC n=258
NCT01739556 TERMINATED
On-treatment PLAtelet Reactivity-guided Therapy Modification FOR ST-segment Elevation Myocardial Infarction
Clinical Centre of Serbia n=242
NCT02934217 COMPLETED
Does Cyclosporine ImpRove Clinical oUtcome in ST Elevation Myocardial Infarction Patients at 3 Years of Follow-up. CIRCUS II Study
Hospices Civils de Lyon n=868
NCT00781118 COMPLETED
AngelMed for Early Recognition and Treatment of STEMI
Angel Medical Systems n=1,020
NCT01217307 COMPLETED
Metformin to Reduce Heart Failure After Myocardial Infarction
University Medical Center Groningen n=380
NCT02290080 COMPLETED
Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers
Karolinska Institutet n=175
NCT01787110 COMPLETED
An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction
Karolinska Institutet n=6,629
NCT00789724 COMPLETED
Anakinra to Prevent Post-infarction Remodeling
Virginia Commonwealth University n=10
NCT02075125 TERMINATED
Prasugrel and Ticagrelor in ST-segment Elevation Myocardial Infarction
Dong-A University n=39
NCT01531114 COMPLETED
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
Gennaro Sardella n=50
NCT01286116 TERMINATED
A Multinational Trial To Evaluate The Parachute Implant System
CardioKinetix, Inc n=59
NCT00729430 COMPLETED
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
Brigham and Women's Hospital n=358
NCT00856765 COMPLETED
Drug-eluting Balloon in Acute Myocardial Infarction
UMC Utrecht n=150
NCT01732341 TERMINATED
Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction
Stentys n=318
NCT01186445 COMPLETED
Morphine In Acute Myocardial Infarction
French Cardiology Society n=94
NCT02271178 TERMINATED
Multi-cap for Increase Adherence After Acute Myocardial Infarction
Hospital El Cruce n=100
NCT01930591 COMPLETED
Ticagrelor for PCI Post Thrombolysis
Unity Health Toronto n=140
NCT01882179 COMPLETED
Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
University College, London n=61
NCT02672267 COMPLETED
A Study of Allogeneic Low Oxygen Mesenchymal Bone Marrow Cells in Subjects With Myocardial Infarction
Altaco XXI, LLP n=50
NCT01167751 COMPLETED
Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction
Royan Institute n=90
NCT01327534 COMPLETED
Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
Stiftung Institut fuer Herzinfarktforschung n=63
NCT02146664 WITHDRAWN
DLBS1033 for Acute NSTEMI Without Early Coronary Revascularization
Dexa Medica Group
NCT01328912 COMPLETED
Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients
Queen's University n=429
NCT01225562 COMPLETED
Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin
AstraZeneca n=21,379
NCT01388504 COMPLETED
Nitrites in Acute Myocardial Infarction
University of Aberdeen n=200
NCT01543555 COMPLETED
Lowering the Risk of Operative Complications Using Atorvastatin Loading Dose
Hospital do Coracao n=648
NCT00872001 TERMINATED
The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)
Merck Sharp & Dohme LLC n=3,080
NCT01356992 TERMINATED
Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation
Eurofarma Laboratorios S.A. n=62
NCT02070679 COMPLETED
Efficacy of Vitamin E in Preventing Contrast-Induced Acute Kidney Injury Following Coronary Angiography
Urmia University of Medical Sciences n=284
NCT01059136 COMPLETED
Aldosterone Blockade Early After Acute Myocardial Infarction
Assistance Publique - Hôpitaux de Paris n=1,603
NCT01650662 COMPLETED
CYCLosporinE A in Reperfused Acute Myocardial Infarction
Mario Negri Institute for Pharmacological Research n=410
NCT00674375 COMPLETED
Risk Score Alerts for Chest Pain Care
Harvard Vanguard Medical Associates n=8,000
NCT01608100 COMPLETED
Evaluation of a New Cardiac Biomarker Assay
Abbott Diagnostics Division n=1,101
NCT01360242 COMPLETED
Minimal Invasive Procedure for Myocardial Infarction
Centre Hospitalier Annecy Genevois n=160
NCT01839890 COMPLETED
Paclitaxel Eluting Balloon in St Elevation Myocardial Infarction
Francisco Javier Goicolea n=202
NCT00886444 COMPLETED
Comparative Evaluation of Various Combinable Magnetic Resonance (CMR) Pulse-sequences for Macrophage Imaging Using Ferucarbotran
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF) n=20
NCT01379261 COMPLETED
Efficacy of Endovascular Catheter Cooling Combined With Cold Saline for the Treatment of Acute Myocardial Infarction
Region Skane n=120
NCT00809965 COMPLETED
An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. n=15,526
NCT01321255 COMPLETED
Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention.
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III n=2,118
NCT01084239 COMPLETED
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Massachusetts General Hospital n=1,000
NCT01390142 COMPLETED
Remote Ischemic Preconditioning Combined to Local Ischemic Postconditioning in Acute Myocardial Infarction
University Hospital, Angers n=60
NCT00781404 COMPLETED
Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI
David Garcia-Dorado n=201
NCT00894023 TERMINATED
Intracoronary Abciximab With Clearway Catheter
Gennaro Sardella n=150
NCT01187654 COMPLETED
Bone Marrow Derived AC 133+ and Mono-Nuclear Cells (MNC) Implantation in Myocardial Infarction (MI) Patient
Royan Institute n=80
NCT01336348 COMPLETED
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
Università degli Studi di Ferrara n=100
NCT00865722 COMPLETED
Remote Postconditioning in Patients With Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention (PCI)
Fondazione IRCCS Policlinico San Matteo di Pavia n=96
NCT01642667 COMPLETED
Pharmacoinvasive Therapy With Prourokinase
Suzhou Landing Pharmaceuticals n=197
NCT00882635 COMPLETED
The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study
Robert Welsh n=44
NCT00590070 COMPLETED
THE REOPEN-AMI STUDY - Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction
Catholic University of the Sacred Heart n=240
NCT01073800 COMPLETED
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
University of Alberta n=100
NCT01338909 COMPLETED
Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Reactivity in Patients With ST-elevation Myocardial Infarction (STEMI)
University of Patras n=35
NCT00821834 COMPLETED
Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being Planned
Sanofi n=1,003
NCT00712101 COMPLETED
Abciximab i.v. Versus i.c. in ST-elevation Myocardial Infarction
University of Leipzig n=1,912
NCT00972270 TERMINATED
Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability
Abiomed Inc. n=1
NCT00650975 TERMINATED
ThromboAblation in Acute Myocardial Infarction
KCRI n=78
NCT00640991 COMPLETED
REsearching Coronary REduction by Appropriately Targeting Euglycemia (RECREATE Pilot Study)
Population Health Research Institute n=500
NCT01109134 COMPLETED
Tirofiban Intracoronary Bolus-only Versus Intravenous Bolus Plus Infusion in STEMI Patients
Kosuyolu Heart Hospital n=49
NCT00607178 COMPLETED
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
Shahid Beheshti University of Medical Sciences n=300
NCT00607217 COMPLETED
The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases
Shahid Beheshti University of Medical Sciences n=360

Full Myocardial Infarction Pipeline

Every sponsor, every trial across Phase 1–4. Sortable, filterable, exportable.

Unlock with Pro

Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only